AXSM Form 144: Proposed sale of 49,666 shares

AXSM filed a Form 144 notifying of a proposed sale of 49,666 shares of Common Stock.

Rhea-AI Filing Summary

AXSM filed a Form 144 notifying of a proposed sale of 49,666 shares of Common Stock. The shares were acquired as compensation (stock options) and the planned method is described as a cashless exercise / same-day sale using Goldman Sachs & Co. LLC as broker. The filing records prior sales by Herriot Tabuteau of 24,835 shares on 06/09/2026 with dollar amounts shown in the excerpt. The notice lists 07/01/2026 as a filing-related date and NASD as the market/brokerage association.

Insights

Securities Attorney

Form 144 reports a proposed Rule 144 sale of compensation-derived shares via cashless exercise.

The filing states 49,666 shares of Common Stock are proposed for sale and labels the acquisition as "compensation -- Stock Options." The planned distribution method is "cashless exercise / same-day sale," which is a common route for option-derived shares.

Timing and exact proceeds are tied to market execution and brokerage facilitation; the excerpt names Goldman Sachs & Co. LLC and notes prior sales of 24,835 shares on 06/09/2026. Cashflow treatment and final proceeds depend on the executed transaction details.

Equity Capital Markets Analyst

Notice signals potential near-term share supply from an option exercise and immediate sale.

The filing links the shares to a compensation grant (stock options) and a cashless exercise approach, which often converts option-derived positions into marketable shares while covering exercise obligations. Goldman Sachs is listed as the broker.

Past reported sales by the same filer — 24,835 shares on 06/09/2026 — provide context for recent disposition activity. Actual market impact depends on execution size and timing.

Key Figures

Proposed shares to sell: 49,666 shares Prior shares sold: 24,835 shares Proceeds shown (first entry): $5,950,195.30 +2 more

5 metrics

Proposed shares to sell 49,666 shares Form 144 proposed sale

Prior shares sold 24,835 shares Sale by Herriot Tabuteau on 06/09/2026

Proceeds shown (first entry) $5,950,195.30 Dollar amount listed alongside 24,835-share sale

Proceeds shown (second entry) $6,020,552.85 Alternate dollar amount listed alongside 24,835-share sale

Filing-related date 07/01/2026 Date listed in securities table

Key Terms

cashless exercise, same-day sale, Form 144

3 terms

cashless exercise financial

"Compensation -- Cashless exercise / same-day sale"

A cashless exercise is a way for an option holder to convert stock options into actual shares without paying the purchase price in cash; instead they immediately give up a portion of the newly issued shares to cover the cost and any withholding taxes. Investors care because this process increases the number of shares available and can slightly dilute existing holdings, while also signaling how insiders or employees are realizing compensation without needing cash — similar to paying for a purchase by handing over part of what you just bought.

same-day sale financial

"Compensation -- Cashless exercise / same-day sale"

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

What does AXSM's Form 144 report?

The Form 144 reports a proposed sale of 49,666 shares of Common Stock acquired as compensation (stock options). It lists cashless exercise / same-day sale as the planned method and names Goldman Sachs & Co. LLC as broker.

Who is the broker listed in the AXSM filing?

The filing lists Goldman Sachs & Co. LLC at 200 West Street, New York, as the broker for the proposed transaction. The excerpt also references NASD in connection with the securities entry.

Has the filer recently sold AXSM shares?

Yes. The excerpt records prior sales by Herriot Tabuteau of 24,835 shares on 06/09/2026, with dollar amounts shown in the excerpt for those transactions. The Form 144 lists the proposed additional sale separately.

How were the proposed shares acquired according to the filing?

The shares were acquired as compensation through stock options (acquisition date shown as 03/15/2017 in the excerpt). The proposed sale is described as a cashless exercise / same-day sale.

What date is associated with AXSM's filing notice?

The excerpt shows 07/01/2026 as a filing-related date in the securities table. It also records prior sale activity dated 06/09/2026 in the sales history.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/01/2026 - 05:35 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001219927
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Axsome Therapeutics, Inc.
SEC File Number	001-37635
Address of Issuer	One World Trade Center 29th Floor New York NEW YORK 10007
Phone	1-212-332-3241
Name of Person for Whose Account the Securities are To Be Sold	Herriot Tabuteau
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	49666	11952619.56	51459766	07/01/2026	NASD

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/15/2017	Acquired as compensation -- Stock Options	The Issuer			49666	03/15/2017	Compensation -- Cashless exercise / same-day sale

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Herriot Tabuteau One World Trade Center 29th Floor New York NY 10007	Common Stock	06/09/2026	24835	5950195.3
Herriot Tabuteau One World Trade Center 29th Floor New York NY 10007	Common Stock	06/09/2026	24835	6020552.85

144: Remarks and Signature

Remarks	The sales of shares set forth herein are made in connection with a selling plan dated 3/10/2026, that is intended to comply with Rule 10b5-1(c).
Date of Notice	07/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Goldman Sachs & Co. LLC on behalf of Herriot Tabuteau
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)